Join UCHAPS for a webinar on how health agencies are improving access to PrEP to prevent new HIV infections in special populations, and ultimately, end the HIV epidemic.
This webinar provides three distinct perspectives on the federal 340B drug discount program - the legal perspective including eligibility, compliance, pharmacy contracting; an experienced pharmacy and discuss important questions to ask when deciding on the right pharmacy partner; and a Ryan White covered entity will provide insights into how the federal 340B drug discount program has helped grow and expand critical services to the most vulnerable patients in SW Pennsylvania.
Join UCHAPS for a webinar where DC Health will share information about their HIV cluster detection and response including partner services, security and confidentiality concerns, questions to consider, coordinating data with neighboring states in the region, and sharing information with community members.
Join UCHAPS for a webinar on mathematical modeling and learn how your health department can use this strategy to end the HIV epidemic.
This document provides an overview of the opioid epidemic and outlines promising practices in opioid overdose prevention and the role of local pharmacies.
NASTAD and UCHAPS host a webinar to provide updates of promising HIV prevention tools, discuss barriers to improve community involvement, ways health departments can address barriers, and an overview of pharmaceutical procedures, processes, restrictions, resources, and guidelines for supporting community engagement.
Since there is no single HIV epidemic and no single pathway to getting to zero new transmissions, UCHAPS proudly introduces “Pathways to Better Urban Health.” Our goal in producing Pathways is to draw new attention to what works and what work lies ahead in our collective ambition to bring an end to new HIV transmissions—for every community and in every community.
This webinar will provide community-based organizations and local health departments guidance to increase elected officials understanding of the importance of public health messages, encourage HIV advocacy, and support HIV prevention efforts.
UCHAPS makes visiting each jurisdiction in its membership a priority to gather best practices and resources in the fight against HIV/AIDS. Information is then shared with members and partners to empower them in their efforts to end the epidemic.
The HIV epidemic affects the health and well-being of African American men and women across the nation. According to the CDC, African Americans account for a high proportion of new HIV diagnoses and people living with HIV compared to other races and ethnicities. Hear what Marc Wayne has to say about this!
Join UCHAPS for our Facebook Live series on how national campaigns can improve public health messaging using modern technology to reach priority populations.
Join UCHAPS for a Facebook Live interview with Adrian Guzman, the Director of Policy and External Affairs at the NYC Department of Health and Mental Hygiene, where he will discuss how the city expanded PrEP access to youth.
UCHAPS has gathered some of the leading professionals that have created unique approaches to increasing access to PrEP and PEP locally. From TelePrEP to 340B rebates, experts will share innovative approaches, share best practices and lessons learned in effectively increasing access to PrEP and PEP.
Mathematical modeling is an important tool in both understanding the spread of infectious disease throughout populations and decision-making for public health departments. This webinar will introduce the basics of commonly used mathematical models for HIV, the benefits and challenges of creating models of HIV transmission, and examples of interventions for HIV prevention created through mathematical modeling.
The ending the epidemic (ETE) plans are put in place to improve the health outcomes of all people living with and vulnerable to the virus and strategically seeks to end the epidemic. The ETE Plans from UCHAPS jurisdictions are available here.
It is critical that those working towards an end to HIV have an understanding of the importance of advocacy, particularly legislative advocacy, as a tool in the fight against HIV. UCHAPS hopes that by providing its members and the larger community of HIV advocates with this guide, we can help advocates to engage in strong, targeted legislative advocacy, particularly at the state and local levels, that will drive the policy and political change necessary to end HIV.
As public health practitioners and community mobilizers, storytelling provides an opportunity to engage in an inquiry and exchange process to design and improve human-centered services and programs. Learn how to develop a storytelling event in your community.
As service providers, we often work to change the world while neglecting ourselves. Our work depletes us and replicates patterns of trauma, trigger, harm, and extraction. This webinar explores the dismantling of the structures that are systematically dehumanizing people living with HIV.
Click to view past UCHAPS monthly newsletters and learn more about the great work happening in our jurisdictions across the nation.
Integrated planning is essential for health departments to develop coordinated and effective systems of HIV/AIDS prevention and care for populations in large urban areas. This session will focus on the experiences of four city health departments and explore the successes and challenges that occurred during their integrated planning processes.
Ending the HIV epidemic must be a local public health policy. Join UCHAPS for webinar on how you can work with your local health department to ensure ending the HIV epidemic remains a top local public health policy.
Join UCHAPS for an interactive webinar on the do’s and dont’s of advocacy as a nonprofit organization. Learn how your organization can be part of a movement without jeopardizing your nonprofit status.
Public health leadership, policy strategists, and community activists discuss changing landscape of healthcare, mounting concerns in the HIV community, and ways that health departments and local HIV organizations can commit to improving drug user health, treating addiction and reducing stigma.
The roundtable will discuss Latino mobilization and engagement; consider policies that hinder HIV prevention efforts; and develop strategies including crafting messaging, selecting a messenger, considering your audience, and educating policymakers. The discussion will end with reflections on and next steps for the Urban Health Agenda.
Join UCHAPS as we discuss supporting youth advocates in a meaningful way with tools, support and resources that are integral to their success. Join us to learn how you can encourage the next generation of advocates.
Click to learn how AIDS Foundation Houston established a PrEP clinic as a 501(c)3 organization.
A panel of national social justice advocates, policy strategists, and community activists discuss changing landscape of healthcare, mounting concerns in the HIV community, and ways that health departments and local HIV organizations can commit to health equity and social justice.
The UCHAPS MHS Resource Center discusses the public health model for MHS, debunks myths about MHS, and identifies its benefits. It also offers program successes and lesson learned from health departments across the nation and several tools for health professionals and laypersons.
UCHAPS is hosted a webinar for UCHAPS membership and others to provide them with an opportunity to speak to 340B experts and learn how upcoming changes to 340B will affect their organizations.
The Health Resources and Services Administration's (HRSA) HIV/AIDS Bureau (HAB) and the Centers for Disease Control and Prevention's (CDC) Division of HIV/AIDS Prevention (DHAP) provided guidance for the development of a integrated HIV prevention and care plan. This new guidance format allows jurisdictions to submit one integrated plan for 2017 - 2021.
This resource center was partially supported by the Cooperative Agreement, #NU65PS004588 funded by the Centers of Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers of Disease Control and Prevention or the Department of Health and Human Services.